This, in turn, suggests that CaMKK2 may restrict the abundance of CD40L+ IFNγ+ TNFa+ effector CD4+ TILs, the density of CD4+ cells per mm3 of tumor volume, and the tumor penetrance of CD4+ T cells. The gene discussed is IFNG; the disease is neoplasm.